Cardiovascular safety of non-steroidal anti-inflammatory drugs in chronic inflammatory rheumatic diseases

被引：5

作者：

Zavodovsky, B. V. ^{[1
]}

Sivordova, L. E. ^{[1
]}

机构：

[1] AB Zborovsky Res Inst Clin & Expt Rheumatol, Volgograd, Russia

来源：

TERAPEVTICHESKII ARKHIV | 2018年 / 90卷 / 08期

关键词：

cardiovascular diseases; cardiovascular risk; rheumatic diseases; rheumatoid arthritis; systemic lupus erythematosus; psoriatic arthritis; ankylosing spondylitis; chronic inflammation; non-steroidal anti-inflammatory drugs; ANKYLOSING-SPONDYLITIS; MYOCARDIAL-INFARCTION; COX-2; INHIBITORS; RISK-MANAGEMENT; ARTHRITIS; ETORICOXIB; MORTALITY; EVENTS; CELECOXIB; NAPROXEN;

D O I：

10.26442/terarkh2018908101-106

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Rheumatic diseases (RD), such as rheumatoid arthritis, systemic lupus erythematosus, ankylosing spondylitis, psoriatic arthritis, vasculitis, gout are associated with increase in cardiovascular morbidity and mortality. The main causes of increased cardiovascular risk are inflammatory heart and vascular lesions, accelerated progression of atherosclerosis and side effects of drug therapy. Non-steroidal anti-inflammatory drugs (NSAIDs) are widely used in clinical practice and are on the list of the most prescribed medications. It is known that NSAIDs have a negative effect on the cardiovascular system (CVS). However NSAIDs may decrease the intensity of inflammation, which is an independent risk risk factor for CVS pathology. Therefore in patients with RD it is theoretically possible to reduce the severity of cardiovascular side effects when using NSAIDs. The article discusses the issues of NSAID's cardiovascular safety, the molecular mechanisms underlying the negative effect of them on CVS, critically evaluated the results of main studies concerning the cardiovascular safety of NSAIDs in chronic inflammatory diseases.

引用

页码：101 / 106

页数：6

共 65 条

[31] Methodology of a large prospective, randomised, open, blinded endpoint streamlined safety study of celecoxib versus traditional non-steroidal anti-inflammatory drugs in patients with osteoarthritis or rheumatoid arthritis: protocol of the standard care versus celecoxib outcome trial (SCOT) [J].

MacDonald, Thomas M. ;

Mackenzie, Isla S. ;

Wei, Li ;

Hawkey, Christopher J. ;

Ford, Ian .

BMJ OPEN, 2013, 3 (01)

[32] Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease Anti-inflammatory Prevention Trial (ADAPT) [J].

Martin, Barbara K. ;

Breitner, John C. S. ;

Evans, Denis ;

Lyketsos, Constantine G. ;

Meinert, Curtis L. .

PLOS CLINICAL TRIALS, 2006, 1 (07)

[33]

Mavrogeni Sophie, 2009, Inflammation & Allergy Drug Targets, V8, P390

[34]

[Насонов Е.Л. Nasonov E.L.], 2017, [Научно-практическая ревматология, Rheumatology Science and Practice, Nauchno-prakticheskaya revmatologiya], V55, P457, DOI 10.14412/1995-4484-2017-457-459

[35]

Nasonov EL., 2008, ANTIFOSFOLIPIDNYI SI

[36]

Nasonov EL, 2017, ROSSIJSKIJ ZH GASTRO, V27, P69, DOI [10.22416/1382-4376-2017-27-5-69-75, DOI 10.22416/1382-4376-2017-27-5-69-75]

[37] The risk of congestive heart failure in rheumatoid arthritis - A population-based study over 46 years [J].

Nicola, PJ ;

Maradit-Kremers, H ;

Roger, VL ;

Jacobsen, SJ ;

Crowson, CS ;

Ballman, KV ;

Gabriel, SE .

ARTHRITIS AND RHEUMATISM, 2005, 52 (02) :412-420

[38] Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis [J].

Nissen, Steven E. ;

Yeomans, Neville D. ;

Solomon, Daniel H. ;

Luescher, Thomas F. ;

Libby, Peter ;

Husni, M. Elaine ;

Graham, David Y. ;

Borer, Jeffrey S. ;

Wisniewski, Lisa M. ;

Wolski, Katherine E. ;

Wang, Qiuqing ;

Menon, Venu ;

Ruschitzka, Frank ;

Gaffney, Michael ;

Beckerman, Bruce ;

Berger, Manuela F. ;

Bao, Weihang ;

Lincoff, A. Michael .

NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) :2519-2529

[39] Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery [J].

Nussmeier, NA ;

Whelton, AA ;

Brown, MT ;

Langford, RM ;

Hoeft, A ;

Parlow, JL ;

Boyce, SW ;

Verburg, KM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1081-1091

[40] Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study [J].

Ogdie, Alexis ;

Yu, YiDing ;

Haynes, Kevin ;

Love, Thorvardur Jon ;

Maliha, Samantha ;

Jiang, Yihui ;

Troxel, Andrea B. ;

Hennessy, Sean ;

Kimmel, Steven E. ;

Margolis, David J. ;

Choi, Hyon ;

Mehta, Nehal N. ;

Gelfand, Joel M. .

ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) :326-332

← 1 2 3 4 5 6 7 →